Glucose in platelet additive solutions: To add or not to add?

Transfusion and Apheresis Science

Volumn 44, Issue 3, 2011, Pages 283-295

  Gyongyossy Issa, Maria I C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Additive solutions; Glycolysis; Metabolism; Mitochondria; PAS; Platelets; ROS; Storage; TCA

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; COLLAGEN; GLUCOSE; GLUTATHIONE; HEXOSE PHOSPHATE; LACTIC ACID; PLATELET ADDITIVE SOLUTION; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; THROMBIN; THROMBOCYTE CONCENTRATE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

ANAEROBIC GLYCOLYSIS; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BLOOD; CELL AGING; CELL METABOLISM; CELL VIABILITY; CIRCULATION; CITRIC ACID CYCLE; CYTOSOL; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL TECHNOLOGY; OXIDATIVE STRESS; PATHOGEN REDUCTION TECHNOLOGY; PATHOGENESIS; PH; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; ULTRAVIOLET IRRADIATION;

BLOOD PLATELETS; BLOOD PRESERVATION; GLUCOSE; HUMANS; PHARMACEUTICAL SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; SWEETENING AGENTS;

EID: 79958702056     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.03.003     Document Type: Article

References (222)

1. Berg J.M., Stryer L., Tymoczko J.L. Biochemistry: international edition 2007, WH Freeman and Company, New York, NY.
2. Kresge N., Simoni R.D., Hill R.L. Otto Fritz Meyerhof and the elucidation of the glycolytic pathway. J Biol Chem 2005, 280:e3.
3. Lipmann F. Reminiscences of Embden's formulation of the Embden-Meyerhof cycle. Mol Cell Biochem 1975, 6:171-175.
4. Cartledge S., Candy D.J., Hawker R.J. Citrate metabolism by human platelets. Transfus Med 1997, 7:211-215.
5. Picker S.M., Schneider V., Oustianskaia L., Gathof B.S. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion 2009, 49:2311-2318.
6. Holmsen H. Biochemistry of the platelet: energy metabolism. Hemostasis and thrombosis 1987, 631-643. Lippincott, Philadelphia, PA. R.W. Colman (Ed.).
7. Guppy M., Abas L., Arthur P.G., Whisson M.E. The Pasteur effect in human platelets: implications for storage and metabolic control. Br J Haematol 1995, 91:752-757.
8. Holmsen H., Farstad M. Energy metabolism. Platelet responses and metabolism 1987, vol. 2:245-254. CRC Press, Boca Raton, FL.
9. Karpatkin S. Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis. J Clin Invest 1967, 46:409-417.
10. Palotti F., Baracca A., Hernandez-Rosa E., Walker W.F., Solanis G., Lenaz G., et al. Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem J 2004, 384:287-293.
11. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20.
12. Salganicoff L., Fukami M.H. Energy metabolism of blood platelets. I. Isolation and properties of platelet mitochondria. Arch Biochem Biophys 1972, 163:726-735.
13. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
14. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell poliferation. Science 2009, 324:1029-1033.
15. Detwiler T.C., Zivkovic R.V. Control of energy metabolism in platelets. A comparison of aerobic and anaerobic metabolism in washed rat platelets. Biochim Biophys Acta 1970, 197:117-126. [maybe not, according to Guppy].
16. Akkerman J.W., Gorter G. Relation between energy production and adenine nucleotide metabolism in human blood platelets. Biochim Biophys Acta 1980, 590:107-116.
17. Leoncini G., Maresca M., Balestrero F., Armani U., Piana A. Some aspects of platelet glucose metabolism in thrombocytosis due to myeloproliferative disorders. Thromb Res 1984, 34:233-239.
18. Niu X., Arthur P., Abas L., Whisson M., Guppy M. Carbohydrate metabolism in human platelets in a low glucose medium under aerobic conditions. Biochim Biophys Acta 1996, 1291:97-106.
19. Baker J.M., Candy D.J., Hawker R.J. Influences of pH on human platelet metabolism. Platelets 2001, 12:333-342.
20. Murphy S., Gardner F.H. Platelet storage at 22°C: role of gas transport across plastic containers in maintenance of viability. Blood 1975, 46:209-218.
21. Akkerman J.W.N., Verhoeven A.J.M. Energy metabolism and function. Platelet responses and metabolism 1987, vol. 3:69-99. CRC Press, Boca Raton, FL.
22. Guppy M., Whisson M.E., Sabaratnam R., Withers P., Brand K. Alternative fuels for platelet storage: a metabolic study. Vox Sang 1990, 59:146-152.
23. Doery J.C., Hirsh J., Cooper I. Energy metabolism in human platelets: interrelationship between glycolysis and oxidative metabolism. Blood 1970, 36:159-168.
24. Chaudhry A.A., Sagone A.L., Metz E.N., Balcerzak S.P. Relationship of glucose oxidation to aggregation of human platelets. Blood 1973, 42:249-258.
25. Akkerman J.W. Carbohydrate metabolism. Platelet responses and metabolism 1987, 189-213. CRC Press, Boca Raton, FL. H. Holmsen (Ed.).
26. Sorbara L.R., Davies-Hill T., Koehler-Stec E.M., Vannucci S.J., Horne M.K., Simpson I.A. Thrombin-induced translocation of GLUT3 glucose transporters in human platelets. Biochem J 1997, 328:511-516.
27. Holmsen H., Robkin L. Effects of antimycin A and 2-deoxyglucose on energy metabolism in washed human platelets. Thromb Haemost 1980, 42:1460-1472.
28. D'Aurelio M., Merlo Pich M., Catani L., Sgarbi G.S., Bovina C., Formiggini G., et al. Decreased Pasteur effect in platelets of aged individuals. Mech Ageing Dev 2001, 122:823-833.
29. Merlo-Pich M., Bovina C., Formiggini G., Cometti G.G., Ghelli A., Parenti Castelli G., et al. Inhibitor sensitivity of respiratory Complex I in human platelets: a possible biomarker of ageing. FEBS Lett 1996, 380:176-178.
30. Schapira A.H.V. Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta 1998, 1366:225-233.
31. Lenaz G., D'Aurelio M., Merlo Pich M., Genova M.L., Ventura B., Bovina C., et al. Mitochondrial bioenergetics in aging. Biochim Biophys Acta 2000, 1459:397-404.
32. Kilkson H., Holme S., Murphy S. Platelet metabolism during storage of platelet concentrates at 22°C. Blood 1984, 64:406-414.
33. Farrugia A., Douglas S., Williams S., Kellner S., Amerena L., James J. Improved in-vitro quality of platelet concentrates stored in a dextrose-free synthetic medium. Transfus Med 1991, 1:31-38.
34. Samudio I., Fiegl M., Andreeff M. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 2009, 69:2163-2166.
35. Chung H.J., Levens D. C-Myc expression: keep the noise down!. Mol Cells 2005, 20:157-166.
36. Galie M., Farace P., Nanni C., Spinelliz A., Nicolato E., Boschi F., et al. Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism. Neoplasia 2007, 9:900-908.
37. Dang C.V., Le A., Gao P. MYC-Induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009, 15:6479-6483.
38. Lozano M.L., Rivera J., Bermejo E., Corral J., Perez E., Vicente V. In vitro analysis of platelet concentrates stored in the presence of modulators of 3′,5′ adenosine monophosphate, and organic anions. Transfus Sci 2000, 22:3-11.
39. Murphy S., Munoz S., Parry-Billings M., Newsholme E. Amino acid metabolism during platelet storage for transfusion. Br J Haematol 1992, 81:585-590.
40. Vasta V., Meacci E., Farnararo M., Bruni P. Glutamine utilization in resting and stimulated platelets. J Biochem 1993, 14:163-166.
41. Guppy M., Abas L., Neylon C., Whisson M.E., Pethick D.W., Niu X. Fuel choices by human platelets in human plasma. Eur J Biochem 1997, 244:161-167.
42. Guppy M., Hill D.J., Arthur P., Rowley A.F. Differences in fuel utilization between trout and human thrombocytes in physiological media. J Comp Physiol B 1999, 169:515-520.
43. Donabedian R., Nemerson Y. Fatty acid oxidation by human platelets and its stimulation by thrombin. Am J Physiol 1971, 221:1283-1286.
44. Cesar J., DiMinno G., Alam I., Silver M., Murphy S. Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 1987, 27:434-437.
45. Hogman C.F. How can we improve platelet preparation and storage?. Transfus Sci 1996, 17:545-551.
46. Cohen P., Wittels B. Energy substrate metabolism in fresh and stored human platelets. J Clin Invest 1970, 49:119-127.
47. Murphy S. The oxidation of exogenously added organic anions by platelets facilitates maintenance of pH during their storage for transfusion at 22°C. Blood 1995, 85:1929-1935.
48. Whisson M.E., Nakhoul A., Howman P., Niu X., Guppy M. Quantitative study of starving platelets in a minimal medium: maintenance by acetate or plasma but not by glucose. Transfus Med 1993, 3:103-113.
49. Ghigo D., Treves S., Bussolino F., Libero L., Orzan F., Bazzan M., et al. Platelet arachidonic acid metabolism in patients with cardiovascular disorders. Biomed Biochim Acta 1988, 47:S299-302.
50. Cowan D.H.P. Latelet metabolism in acute leukemia. J Lab Clin Med 1973, 82:54-66.
51. Skripchenko A., Myrup A., Thompson-Montgomery D., Awatefe H., Moroff G., Wagner S.J. Periods without agitation diminish platelet mitochondrial function during storage. Transfusion 2010, 50:390-399.
52. Mathupala S.P., Ko Y.H., Pedersen P.L. Hexokinase-2 bound to mitochondria: cancer's stygian link to the " Warburg effect" and a pivotal target for effective therapy. Semin Cancer Biol 2009, 19:17-24.
53. Crabtree H.G. Observations on the carbohydrate metabolism of tumours. Biochem J 1929, 23:536-545.
54. Ruckenstuhl C., Buttner S., Carmona-Gutierrez C., Eisenberg T., Kroemer G., Sigrist S.J., et al. The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer. PLoS ONE 2009, 4(2):e4592.
55. Adams G.A., Rock G. Storage of human platelet concentrates in an artificial medium without dextrose. Transfusion 1988, 28:217-220.
56. Bertolini F., Murphy S., Rebulla P., Sirchia G. Role of acetate during platelet storage in a synthetic medium. Transfusion 1992, 32:152-156.
57. Shimizu T., Murphy S. Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate-containing additive solution. Transfusion 1993, 33:304-310.
58. de Wildt-Eggen J., Gulliksson H. In vivo and in vitro comparison of platelets stored in either synthetic media or plasma. Vox Sang 2003, 84:256-264.
59. Gulliksson H. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003, 17:209-215.
60. Gulliksson H., Aubuchon J.P., Cardigan R., Van Der Meer P.F., Murphy S., Prowse C., et al. Storage of platelets in additive solutions: a multicenter study of the in vitro effects of potassium and magnesium. Vox Sang 2003, 85:199-205.
61. Fritz I.B. Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. Physiol Rev 1961, 41:52-129.
62. Kitchens C.S., Newcomb T.F. Human platelet respiration. J Appl Physiol 1968, 25:581-585.
63. Nishimura J., Minakami S. Effect of hydrogen ion concentration on energy metabolism in pig platelets. Biochim Biophys Acta 1975, 396:1-10.
64. Li J., Goodrich L., Hansen E., Edrich R., Gampp D., Goodrich R.P. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage. Transfusion 2005, 45:1750-1758.
65. Kaufman R.M. Platelets: testing, dosing and the storage lesion-recent advances. Hematol Am Coc Hematol Educ Program 2006, 492-496.
66. Picker S.M., Oustianskaia L., Schneider V., Gathof B.S. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction. Vox Sang 2009, 97:26-33.
67. Pecqueur C., Alves-Guerra C., Ricquier D., Bouillaud F. UCP2, a metabolic sensor coupling glucose oxidation to mitochondrial metabolism?. Life 2009, 61:762-767.
68. Kaadige M.R., Looper R.E., Kamalanaadhan S., Ayer D.E. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc Natl Acad Sci USA 2009, 106:14878-14883.
69. van der Meer P.F., Pietersz R.N.I., Reesink H.W. Comparison of two platelet additive solutions. Transfus Med 2001, 11:193-197.
70. van der Meer P.F., Gulliksson H., AuBuchon J.P., Prowse C., Richter E., de Wildt-Eggen J. Interruption of agitation of platelet concentrates: effects on in vitro parameters. Vox Sang 2005, 89:227-234. Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
71. Dumont L.J., Gulliksson H., van der Meer P.F., Murphy S., Nixon J.G., de Wildt-Eggen J., et al. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Transfusion 2007, 47:1666-1673.
72. Bode A.P., Holme S., Heaton W.A., Swanson M.S. Extended storage of platelets in an artificial medium with the platelet activation inhibitors prostaglandin E1 and theophylline. Vox Sanguinis 1991, 60:105-112.
73. Lechi C., Arosio E., Zannoni M., Guzzo P., Delva P., Montesi G., et al. Platelet intracellular pH and glucose metabolism in hypertensive patients. J Human Hypertension 1993, 7:39-42.
74. Goodrich R.P., Li J., Pieters H., Crookes R., Roodt J., Heyns A.du P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006, 90:279-285.
75. Werle M., Jahn J., Kreuzer J., Hofele J., Elsasser A., Ackermann C., et al. Metabolic control analysis of the Warburg-effect in proliferating vascular smooth muscle cells. J Biomed Sci 2005, 12:827-834.
76. Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer 2008, 8:51-56.
77. Takayama N., Nishimura S., Nakamura S., Shimizu T., Ohnishi R., Endo H., et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010, 207. 10.1084/jem.2010084.
78. Heijnen H.F., Oorschot V., Sixma J.J., Slot J.W., James D.E. Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface. J Cell Biol 1997, 138:323-330.
79. Stenberg P.E., Shuman M.A., Levine S.P., Bainton D.F. Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol 1984, 98:748-760.
80. Kumagai S., Narasaki R., Hasumi K. Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells. Biochem Biophys Res Commun 2008, 365:362-368.
81. Akkerman J.W., Gorter G., Sixma J.J., Staal G.E.J. Variations in levels of glycolytic intermediates in human platelets during platelet-collagen interaction. Biochim Biophys Acta 1976, 421:296-307.
82. Akkerman J.W. Regulation of carbohydrate metabolism in platelets. A review. Thromb Haemost 1978, 39:712-724.
83. Verhoeven A.J., Verhaar R., Gouwerok E.G.W., de Korte D. The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion 2005, 45:82-89.
84. Badlou B.A., Ilseldijk M.J.W., Smid W.M., Akkerman J.W.N. Prolonged platelet preservation by transient metabolic suppression. Transfusion 2005, 45:214-222.
85. Badlou B.A., van der Meer P.F., Akkerman J.W.N., Smid W.M., Pietersz R.N.I. Metabolic energy reduction by glucose deprivation and low gas exchange preserves platelet function after 48h storage at 4°C. Vox Sang 2007, 92:311-318.
86. Holme S. Storage and quality assessment of platelets. Vox Sang 1998, 74:207-216.
87. Cardigan R., Williamson L.M. The quality of platelets after storage for 7days. Transfus Med 2003, 13:173-187.
88. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. New Engl J Med 2003, 348:2656-2668.
89. Bohm M., Papezova H., Hansikova H., Wenchich L., Zeman J. Activities of respiratory chain complexes in isolated platelets in females with anorexia nervosa. Int J Eat Disord 2007, 40:659-663.
90. Davey G.P., Peuchen S., Clark J.B. Energy thresholds in brain mitochondria: potential involvement in neurodegeneration. J Biol Chem 1998, 273:12753-12757.
91. Ben-Shachar D., Zuk R., Gazawi H., Reshef A., Sheinkman A., Klein E. Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol 1999, 2:245-253.
92. Ben-Shachar D., Bonne O., Chisin R., Klein E., Lester H., Aharon-Peretz J., et al. Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET study. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:807-813.
93. Marcus A.J., Silk S.T., Safier L.B., Ullmann H.L. Superoxide production and reducing activity in human platelets. J Clin Invest 1977, 59:149-158.
94. Iuliano L., Colavita A.R., Leo R., Praticò D., Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med 1997, 22:999-1006.
95. Kushnareva Y., Murphy A.N., Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J 2002, 368:545-553.
96. Seno T., Inoue N., Gao D., Okuda M., Sumi Y., Matsui K., et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 2001, 103:399-409.
97. Bressler N.M., Broekman M.J., Marcus A.J. Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. Blood 1979, 53:167-178.
98. Burch J.W., Burch P.T. Glutathione disulfide production during arachidonic acid oxygenation in human platelets. Prostaglandins 1990, 39:123-134.
99. Freedman J.E. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008, 28:s11-s16.
100. Fibach E., Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med 2008, 8:609-619.
101. Mills D.B. Changes in the adenylate energy charge in human blood platelets induced by adenosine diphosphate. Nature 1973, 243:220.
102. Holmsen H. Energy metabolism and platelet responses. Vox Sang 1981, 40:1-7.
103. Tomasiak M., Stelmach H., Rusak T., Wysocka J. Nitric oxide and platelet energy metabolism. Acta Biochim Pol 2004, 51:789-803.
104. Akkerman J.W.N., Driver H.A., Dangelmaier C.A., Holmsen H. Alterations in 32P-labelled intermediates during flux activation of human platelet glycolysis. Biochim Biophys Acta 1984, 802:221-228.
105. Yardimci T., Ulutin O.N. Alteration of platelet glucose transport system in atherosclerosis. Wien Klin Wochenschr 1986, 98:221-224.
106. Rusak T., Tomasiak M., Ciborowski M. Peroxynitrite can affect platelet responses by inhibiting energy production. Acta Biochim Polonica 2006, 53:769-776.
107. Maresca M., Colao C., Leoncini G. Generation of hydrogen peroxide in resting and activated platelets. Cell Biochem Funct 1992, 10:79-85.
108. Chen K., Keaney J. Reactive oxygen species-mediated signal transduction in the endothelium. Endothelium 2004, 11:109-121.
109. Brill A., Chauhan A.K., Canault M., Walsh M.T., Bergmeier W., Wagner D.D. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res 2009, 84:137-144.
110. Holme S., Heaton W.A., Whitley P. Platelet storage lesions in second-generation containers: correlation with in vivo behavior with storage up to 14days. Vox Sang 1990, 59:12-18.
111. Rinder H.M., Murphy M., Mitchell J.G., Stocks J., Ault K.A., Hillman R.S. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991, 31:409-414.
112. Merten M., Chow T., Hellums J.D., Thiagarajan P. A new role for P-selectin in shear-induced platelet aggregation. Circulation 2000, 102:2045-2050.
113. Albanyan A.M., Harrison P., Murphy M.F. Markers of platelet activation and apoptosis during storage of apheresis and buffy coat-derived platelet concentrates for 7days. Transfusion 2009, 49:108-117.
114. Sweeney J.D., Arduini A. L-carnitine and its possible role in red cell and platelet storage. Transfus Med Rev 2004, 18:58-65.
115. Perrotta P.L., Perrotta C.L., Snyder E.L. Apoptotic activity in stored human platelets. Transfusion 2003, 43:526-535.
116. Li J., Xia Y., Bertino A.M., Coburn J.P., Kuter D.J. The mechanism of apoptosis in human platelets during storage. Transfusion 2000, 40:1320-1329.
117. Zhang J.G., Carter C.J., Culibrk B., Devine D.V., Levin E., Scammell K., et al. Buffy-coat platelet parameters and metabolism during storage in additive solutions or plasma. Transfusion 2008, 48:847-856.
118. Dijkstra-Tiekstra M.J., Kuipers W., Setroikromo A.C., de Wildt-Eggen J. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates. Transfusion 2008, 48:2114-2121.
119. Murphy S., Rebulla P., Bertolini F., Holme S., Moroff G., Snyder E., et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Foce of the International Society of Blood Transfusion. Transfus Med Rev 1994, 8:29-36.
120. Lopez J.J., Salido G.M., Gómez-Arteta E., Rosado J.A., Pariente J.A. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 2007, 5:1283-1291.
121. Pignatelli P., Pulcinelli F.M., Lenti L., Gazzaniga P.P., Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998, 91:484-490.
122. Caccese D., Pratico D., Ghiselli A., Natoli S., Pignatelli P., Sanguigni V., et al. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation: role of arachidonic acid metabolism. Thromb Haemost 2000, 83:485-490.
123. Yamagishi S., Edelstein D., Du X., Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001, 50:1491-1494.
124. Sa Y.L., Huang S.J. Effects of activated complements on platelets. Acta Pharmacol Sin 2003, 24:675-680.
125. Matarrese P., Straface E., Palumbo G., Anselmi M., Gambardella G., Ascione B., et al. Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A - activation and long-term commitment to cell death. FEBS J 2009, 276:845-856.
126. Nowak P., Wachowicz B. Studies on pig blood platelet responses to peroxynitrite action. Platelets 2001, 12:376-381.
127. Wachowicz B., Olas B., Zbikowska H.M., Buczynski A. Generation of reactive oxygen species in blood platelets. Platelets 2002, 13:175-182.
128. Ceriello A., Giugliano D., Quatraro A., Dello Russo P., Lefebvre P.J. Metabolic control may influence the increased superoxide anion generation in diabetic serum. Diabet Med 1991, 8:540-542.
129. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001, 88:756-762.
130. Brown G.C. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999, 1411:351-369.
131. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 2001, 1504:46-57.
132. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem J 1973, 34:707-716.
133. Pereira J., Soto M., Palomo I., Ocqueteau M., Coetzee L.M., Astudillo S., et al. Platelet aging in vivo is associated with activation of apoptotic pathways: studies in a model of suppressed thrombopoiesis in dogs. Thromb Haemost 2002, 87:905-909.
134. Bergmeier W., Piffath C.L., Cheng G., Dole V.S., Zhang Y., von Andrian U.H., et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIb alpha shedding from platelets in vitro and in vivo. Circ Res 2004, 95:677-683.
135. Sies H. Biochemistry of oxidative stress. Angew Chem Int Ed Engl 1986, 25:1058-1071.
136. Ferreira I.L., Nascimento M.V., Ribeiro M., Almeida S., Cardoso S.M., Grazina M., et al. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp Neurol 2010, 222:243-255.
137. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J Neurochem 1994, 63:793-807.
138. Cardoso S.M., Pereira C., Oliveira C.R. Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 1999, 26:3-13.
139. Gotz M.E., Gerstner A., Harth R., Dirr A., Janetzky B., Kuhn W., et al. Altered redox state of platelet coenzyme Q10 in Parkinson's disease. J Neural Transm 2000, 107:41-48.
140. Dror N., Klein E., Karry R., Sheinkman A., Kirsh Z., Mazor M., et al. State dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry 2002, 7:995-1001.
141. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 2006, 26:689-695.
142. Garelnabi M., Gupta V., Mallika V., Bhattacharjee J. Platelets oxidative stress in Indian patients with ischemic heart disease. J Clin Lab Anal 2010, 24:49-54.
143. Owens M., Holme S., Heaton A., Sawyer S., Cardinali S. Post-transfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992, 80:539-544.
144. Murphy S. What's so bad about old platelets?. Transfusion 2002, 42:809-811.
145. Dumont L.J., AuBuchon J.P., Whitley P., Herschel L.H., Johnson A., McNeil D., et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002, 42:847-854.
146. Murphy S. The efficacy of synthetic media in the storage of human platelets for transfusion. Transfus Med Rev 1999, 13:153-163.
147. Gulliksson H. Additive solutions for the storage of platelets for transfusion. Transfus Med 2000, 10:257-264.
148. Gulliksson H., Larsson S., Kumlien G., Shanwell A. Storage of platelets in additive solutions: effect of phosphate. Vox Sang 2000, 78:176-184.
149. Shimizu T., Shibata K., Kora S.I. First autoclave sterilized platelet additive solution containing glucose with a physiological pH for the preparation of plasma poor platelet concentrates. Vox Sang 1992, 62:87-93.
150. Prowse C., Waterston Y.G., Dawes J., Farrugia A. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant. Vox Sang 1987, 52:257-264.
151. Hunter S., Nixon J., Murphy S. The effect of the interruption of agitation on platelet quality during storage for transfusion. Transfusion 2001, 41:809-814.
152. Wagner S.J., Myrup A., Awatefe H., Thompson-Montgomery D., Hirayama J., Skripchenko A. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation. Transfusion 2008, 48:2501-2507.
153. Adams G.A., Swenson S.D., Rock G. Survival and recovery of human platelets stored for five days in a non-plasma medium. Blood 1986, 67:672-675.
154. Rock G., White J., Labow R. Storage of platelets in balanced salt solutions: a simple platelet storage medium. Transfusion 1991, 31:21-25.
155. Holme S. Platelet storage in a liquid environment. Transfus Sci 1994, 15:117-130.
156. Holme S. Effect of additive solutions on platelet biochemistry. Blood Cells 1992, 18:421-430.
157. MacIver N.J., Jacobs S.R., Wieman H.L., Wofford J.A., Coloff J.L., Rathmell J.C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008, 84:949-957.
158. Heaton W.A.L., Holme S., Keegan T. Development of a combined storage medium for 7-day storage of platelet concentrates and 42-day storage of red cell concentrates. Br J Haematol 1990, 75:400-407.
159. Gyongyossy-Issa M.I.C., Zhang J.G., Culibrk B., Hunter F., Levin E., Scammell K., et al. Novel system for storage of buffy-coat derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma. Vox Sang 2009, 97:102-109.
160. Azuma H., Hirayama J., Akino M., Miura R., Kiyama Y., Imai K., et al. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2009, 49:214-218.
161. Sandgren P., Mayaudon V., Payrat J.M., Sjödin A., Gulliksson H. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over. Vox Sang 2010, 98:415-422.
162. Gulliksson H., Eriksson L., Hogman C.F., Payrat J.M. Buffy-coat derived platelet concentrates prepared from half- strength citrate CPD and CPD whole blood units. Comparison between three additive solutions: in vitro studies. Vox Sang 1995, 68:152-159.
163. Diedrich B., Sandgren P., Jansson B., Gulliksson H., Svensson L., Shanwell A. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008, 94:96-102.
164. Weis-Fogh U.S. The effect of citrate, calcium, and magnesium ions on the potassium movement across the human platelet ions on the potassium movement across the human platelet membrane. Transfusion 1985, 25:339-342.
165. Gawaz M., Ott I., Reininger A.J., Neumann F.J. Effects of magnesium on platelet aggregation and adhesion. Thromb Haemost 1994, 72:912-918.
166. Morimoto T., Ogihara S. ATP is required in platelet serotonin exocytosis for protein phosphorylation and priming of secretory vesicles docked on the plasma membrane. J Cell Sci 1996, 109:113-118.
167. Hsiao G., Shen M.-Y., Chou D.-S., Linb C.-H., Chkn T.-F., Sheu J.-R. Involvement of the antiplatelet activity of magnesium sulfate in suppression of protein Kinase C and the Na+/H+ exchanger. J Biomed Sci 2004, 11:19-26.
168. Kimura M., Lu X., Skurnick J., Awad G., Bogden J., Kemp F., et al. Potassium chloride supplementation diminishes platelet reactivity in humans. Hypertension 2004, 44:969-973.
169. Wagner S.J., Skripchenko A., Myrup A., Thompson-Montgomery D., Awatefe H., Moroff G. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels. Transfusion 2010, 50:1028-1035.
170. López J.J., Redondo P.C., Salido G.M., Pariente J.A., Rosado J.A. N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine induces apoptosis through the activation of caspases-3 and -8 in human platelets. A role for endoplasmic reticulum stress. J Thromb Hemost 2009, 7:992-999.
171. Reesink H.W., Panzer S., McQuilten Z.K., Wood E.M., Marks D.C., Wendel S., et al. Pathogen inactivation of platelet concentrates. Vox Sang 2010, 99:85-95.
172. Kerkhoffs J.-L.H., van Putten W.L.J., Novotny V.M.J., TeBoekhorst P.A.W., Scipperus M.R., Zwaginga J.J., et al. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol 2010, 150:209-217.
173. Lin R., Alfonso R., Behrman B., Corten L., Damonte P.B., Dikeman R., et al. Photochemical treatment of platelet concentrates with a novel psoralen and UVA to enhance the safety of platelet transfusions. Infus Ther Trans Med 1998, 25:39-48.
174. van Rhenen D.J., Vermey J., Mayaudon V., Hind C., Lin L., Corash L. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang 2000, 79:206-214.
175. Janetzko K., Klinger M., Mayaudon V., Lin L., Eichler H., Kluter H. Storage characteristics of split double-dose platelet concentrates derived from apheresis and treated with amotosalen-HCl and UVA light for pathogen inactivation. Infus Ther Transfus Med 2002, 29:193-198.
176. Picker S.M., Speer R., Gathof B.S. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004, 44:320-329.
177. Goodrich R.P. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 2000, 78:211-215.
178. Ruane P.H., Edrich R., Gampp D., Keil S.D., Leonard R.L., Goodrich R.P. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004, 44:877-885.
179. AuBuchon J.P., Herschel L., Roger J., Taylor H., Whitley P., Li J., et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005, 45:1335-1341.
180. Mohr H., Steil L., Gravemann U., Thiele T., Hammer E., Greinacher A., et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009, 49:2612-2624.
181. Pamphilon D.H., Corbin S.A., Saunders J., Tandy N.P. Applications of ultraviolet light in the preparation of platelet concentrates. Transfusion 1989, 29:379-383.
182. van Rhenen D., Gulliksson H., Cazenave J.P., Pamphilon D., Ljungman P., Kluter H., et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euro-SPRITE trial. Blood 2003, 101:2426-2433.
183. Janetzko K., Lin L., Eichler H., Mayaudon V., Flament J., Kluter H. Implementation of the INTERCEPT Blood System for platelets into routine blood bank manufacturing procedures: evaluation of aphaeresis platelets. Vox Sang 2004, 86:239-245.
184. Jansen G.A., van Vliet H.H., Vermeij H., Beckers E.A., Leebeek F.W., Sonneveld P., et al. Functional characteristics of photochemically treated platelets. Transfusion 2004, 44:313-319.
185. Snyder E., McCullough J., Slichter S.J., Strauss R.G., Lopez-Plaza I., Lin J.S., et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005, 45:1864-1875.
186. Apelseth T.O., Bruserud O., Wentzel-Larsen T., Bakken A.M., Bjorsvik S., Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007, 47:653-665.
187. Lozano M., Galan A., Mazzara R., Corash L., Escolar G. Leukoreduced buffy-coat derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions. Transfusion 2007, 47:666-671.
188. Janetzko K., Hinz K., Marschner S., Goodrich R., Kluter H. Pathogen reduction technology (Mirasol) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS. Vox Sang 2009, 97:234-239.
189. van der Meer P.F., Kerkhoffs J.L., Curvers J., Scharenberg J., de Korte D., Brand A., et al. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010, 98:517-524.
190. Ito K., Inoue S., Yamamoto K., Kawanishi S. 8-Hydroxydeoxyguanosine formation at the 5' site of 5'-GG-3' sequences in double-stranded DNA by UV radiation with riboflavin. J Biol Chem 1993, 268:13221-13227.
191. Grass J.A., Hei D.J., Metchette K., Cimino G.D., Wiesehahn G.P., Corash L., et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998, 91:2180-2188.
192. Kumar V., Lockerbie O., Keil S.D., Ruane P.H., Platz M.S., Martin C.B., et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004, 80:15-21.
193. Bruchmüller I., Lösel R., Bugert P., Corash L., Lin L., Klüter H., et al. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets. Platelets 2005, 16:441-445.
194. Viola G., Facciolo L., Vedaldi D., Disarò S., Basso G., Dall'Acqua F. Differential response of linear and angular psoralens in PUVA-induced apoptosis in HL-60 cells. Photochem Photobiol Sci 2004, 3:237-239.
195. Heck D.E., Vetrano A.M., Mariano T.M., Laskin J.D. UVB light stimulates production of reactive oxygen species. J Biol Chem 2003, 278:22432-22436.
196. Bakdash N., Williams M.S. Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med 2008, 45:158-166.
197. Barile M., Brizio C., Valenti D., De Virgilio C., Passarella S. The riboflavin/FAD cycle in rat liver mitochondria. Eur J Biochem 2000, 267:4888-4900.
198. Kao Y.-T., Saxena C., He T.-F., Guo L., Wang L., Sancar A., et al. Ultrafast dynamics of flavins in five redox states. J Am Chem Soc 2008, 130:13132-13139.
199. Yoshida L.S., Saruta F., Yoshikawa K., Tatsuzawa O., Tsunawaki S. Mutation at histidine 338 of gp91phox depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase. J Biol Chem 1998, 273:27879-27886.
200. Higashi O., Ishigaki W., Hashimoto T. Effects of Riboflavin-2′,3′,4′,5′-tetrabutyrate and flavin adenine dinucleotide on the platelet aggregation induced by hydrogen peroxide. Tohoku J Exp Med 1978, 124:323-329.
201. Endo Y., Mamiya S., Miura A. Effects of riboflavin-2′,3′,4′,5′-tetrabutyrate on platelet function and plasma lipids. Jpn J Med 1985, 24:13-18.
202. Hoffman D.L., Brookes P.S. Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J Biol Chem 2009, 284:16236-16245.
203. Holme S., Heaton W.A., Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987, 66:233-238.
204. Thon J.N., Devine D.V. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007, 47:2260-2270.
205. Schwertz H., Koster S., Kahr W.H.A., Michetti N., Kraemer B.F., Weitz D.A., et al. Anucleate platelets generate progeny. Blood 2010, 115:3801-3809.
206. Buchholz D.H., Young V.M., Friedman N.R., Reilly J.A., Mardiney M.R. Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion 1973, 13:268-275.
207. Braine H.G., Kickler T.S., Charache P., Ness P.M., Davis J., Reichart C., et al. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 1986, 26:391-393.
208. Heal J.M., Jones M.E., Forey J., Chaudhry A., Stricof L. Fatal Salmonella septicemia after platelet transfusion. Transfusion 1987, 27:2-5.
209. Yomtovian R., Lazarus H.M., Goodnough L.T., Hirschler N.V., Morrissey A.M., Jacobs M.R. A prospective microbiologic surveillance program to detect and prevent transfusion of bacterially contaminated platelets. Transfusion 1993, 33:902-909.
210. Yomtovian R., Jacobs M.R. A prospective bonus of platelet storage additive solutions: a reduction in biofilm formation and improved bacterial detection during platelet storage. Transfusion 2010, 50:2295-2300.
211. Greco C., Mastronardi C., Pagotto F., Mack D., Ramirez-Arcos S. Assessment of biofilm-forming ability of coagulase-negative staphylococci isolated from contaminated platelet preparations in Canada. Transfusion 2008, 48:969-977.
212. Greco C., Martincic I., Gusinjac A., Kalab M., Yang A.F., Ramirez-Arcos S. Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions. Transfusion 2007, 47:1143-1153.
213. Greco C.A., Zhang J.G., Kalab M., Yi Q.L., Ramirez-Arcos S.M., Gyongyossy-Issa M.I. Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates. Transfusion 2010, 50:2344-2352.
214. Dumont L.J., Wood T.A., Housman M., Herschel L., Brantigan B., Heber C.L., et al. Bacteria start growth earlier with slower doubling rates in PAS platelets compared to plate-lets in plasma. Transfusion 2009, 49(Suppl. 3):44A.
215. Dobrynin D., Fridman G., Friedman G., Fridman A. Physical and biological mechanisms of direct plasma interaction with living tissue. New J Phys 2009, 11:1-26.
216. Devine D.V., Serrano K. The platelet storage lesion. Clin Lab Med 2010, 30:475-487.
217. Verhoeven A.J., Mommersteeg M.E., Akkerman J.W. Comparative studies on the energetics of platelet responses induced by different agonists. Biochem J 1986, 236:879-887.
218. Hoffmeister K.M., Felbinger T.W., Falet H., Denis C.V., Bergmeier W., Mayadas T.N., et al. The clearance mechanism of chilled blood platelets. Cell 2003, 112:87-97.
219. Eriksson L., Hogman C.F. Platelet concentrates in an additive solution prepared from pooled buffy coats. Vox Sang 1990, 59:140-145.
220. Murphy S., Kagen L., Holme S., Gottlieb B., Heaton W., Grode G., et al. Platelet storage in synthetic media lacking glucose and bicarbonate. Transfusion 1991, 31:16-20.
221. Bertolini F., Rebulla P., Porretti L., Murphy S. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose free crystalloid medium. Transfusion 1992, 32:9-16.
222. Ramírez-Arcos S., Chin-Yee I., Hume H., Fearon M., Goldman M., Eckert K., et al. Fatal septic shock associated with transfusion-transmitted Serratia marcescens. Transfusion 2006, 46:679-681.